TherapeuticsMD, Inc.

TXMD

US88338N2062

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.86 ^USD	-0.53%		0.00%	-17.33%

Mar. 29	TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 06	Knight Therapeutics Announces Launch of Bijuva in Canada	MT

TherapeuticsMD : Thinking about buying stock in Ovid Therapeutics, KemPharm, Super League Gaming, Heat Biologics, or TherapeuticsMD?

March 03, 2021 at 08:31 am EST

NEW YORK, March 3, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OVID, KMPH, SLGG, HTBX, and TXMD.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

OVID: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=OVID&prnumber=030320211
KMPH: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=KMPH&prnumber=030320211
SLGG: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=SLGG&prnumber=030320211
HTBX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=HTBX&prnumber=030320211
TXMD: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=TXMD&prnumber=030320211

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-ovid-therapeutics-kempharm-super-league-gaming-heat-biologics-or-therapeuticsmd-301239646.html

SOURCE InvestorsObserver

Latest news about TherapeuticsMD, Inc.

TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Knight Therapeutics Announces Launch of Bijuva in Canada	Feb. 06	MT
Knight Therapeutics Announces Product Launch For IMVEXXY In Canada	Jan. 04	MT
North American Morning Briefing : Stocks Seen Building on CPI Rally; PPI Data Due	Nov. 15	DJ
TherapeuticsMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
TherapeuticsMD, Inc. Announces Evaluation of Strategic Alternatives	Nov. 13	CI
TherapeuticsMD, Inc. Announces Executive Changes	23-08-18	CI
TherapeuticsMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
North American Morning Briefing : Stock Futures -2-	23-08-14	DJ
TherapeuticsMD, Inc.(NasdaqGS:TXMD) added to Russell 3000E Growth Index	23-06-23	CI
TherapeuticsMD, Inc.(NasdaqGS:TXMD) added to Russell Microcap Index	23-06-23	CI
TherapeuticsMD, Inc.(NasdaqGS:TXMD) added to Russell Microcap Value Index	23-06-23	CI
TherapeuticsMD, Inc.(NasdaqGS:TXMD) added to Russell 3000E Value Index	23-06-23	CI
TherapeuticsMD, Inc.(NasdaqGS:TXMD) added to Russell Microcap Growth Index	23-06-23	CI
TherapeuticsMD, Inc.(NasdaqGS:TXMD) added to Russell 3000E Index	23-06-23	CI
TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
TherapeuticsMD, Inc. announced that it expects to receive $5 million in funding from Rubric Capital Management LP	23-04-30	CI
TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-07	CI
TherapeuticsMD, Inc. Auditor Raises 'Going Concern' Doubt	23-04-06	CI
North American Morning Briefing : Stocks Seen -2-	23-03-30	DJ
North American Morning Briefing : Traders Reassess -2-	23-03-23	DJ
North American Morning Briefing : Some Calm -2-	23-03-16	DJ
Cantor Fitzgerald Reinstates TherapeuticsMD at Neutral With $5 Price Target	23-01-11	MT
TherapeuticsMd, Inc. Announces Chief Executive Officer Changes	23-01-06	CI
TherapeuticsMd, Inc. Announces Executive Changes	23-01-06	CI

Chart TherapeuticsMD, Inc.

Duration

Period

More charts

Company Profile

TherapeuticsMD, Inc. is a healthcare company. The Company is focused on developing and commercializing products exclusively for women. It is engaged in conducting business by out-licensing its products and collecting royalties, after granting a license to commercialize the Company's IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands in the United States and its possessions and territories and assigning the Companyâs exclusive license to commercialize ANNOVERA in the United States and its possessions and territories to Mayne Pharma. ANNOVERA is a one-year (13 cycles) ring-shaped contraceptive vaginal system (CVS)). ANNOVERA, which is made with a silicone elastomer, contains segesterone acetate, a 19-nor progesterone derivative also known as Nestorone (SA) and ethinyl estradiol (EE). Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.

Sector

Pharmaceuticals

Calendar

2024-05-06 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
THERAPEUTICSMD, INC.	-17.33%	21.57M
MERCK KGAA	+5.31%	69.91B
KYOWA KIRIN CO. LTD.	+10.97%	9.03B
SK BIOPHARMACEUTICALS CO., LTD.	-16.83%	4.75B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+43.48%	4.31B
YUHAN CORPORATION	+3.20%	3.88B
INDIVIOR PLC	+18.82%	2.37B
BETTA PHARMACEUTICALS CO., LTD.	-21.36%	2.26B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-29.67%	2.2B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+8.38%	1.98B

Specialty & Advanced Pharmaceuticals

TherapeuticsMD, Inc.

Equities

TXMD

US88338N2062

Pharmaceuticals

TherapeuticsMD : Thinking about buying stock in Ovid Therapeutics, KemPharm, Super League Gaming, Heat Biologics, or TherapeuticsMD?

Latest news about TherapeuticsMD, Inc.

Chart TherapeuticsMD, Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Specialty & Advanced Pharmaceuticals